FUNDINGClinical ink Lands New PE Owners In Ardan-GI DealClinical ink announced new equity investments from Ardan Equity and GI Partners in a co-control partnership, with GI Partners Fund V fully exiting its stake after backing the clinical-trial technology company since 2020.Oct 19, 2026DEEP DIVE